Journal Article Summary

The article investigates the effects of two inhaled corticosteroids, hydrofluoroalkane (HFA) formulations of fluticasone propionate (FP) and beclomethasone dipropionate (BDP), on adrenal suppression. Understanding the systemic safety profiles of these medications is crucial, especially since they are commonly used to manage respiratory conditions like asthma. The study aims to provide insights into how different doses of these inhalers affect cortisol levels in the body, which is important for assessing potential side effects related to adrenal function.

In this study, sixteen healthy volunteers participated in a controlled trial where they received either HFA-FP or HFA-BDP over three weeks, with doses gradually increasing to 2000 µg per day. Researchers measured cortisol levels in urine and blood to assess adrenal suppression after each treatment period. The findings revealed that both medications suppressed cortisol levels, but HFA-BDP caused a greater reduction in the urinary cortisol/creatinine ratio compared to HFA-FP at the 1000 µg dose. This suggests that while both medications can affect adrenal function, BDP may have a stronger impact at certain doses.

The study has limitations, including a small sample size and the fact that it only involved healthy volunteers, which may not fully represent the effects in patients with respiratory conditions. Patients should be aware of the potential for adrenal suppression when using these inhalers and discuss any concerns with their healthcare provider, especially if they experience symptoms like fatigue or weakness. It is important for patients to have open conversations about their treatment options and any risks associated with inhaled corticosteroids.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Fowler Stephen J, Orr Linda C, Wilson Andrew M, Sims Erika J, Lipworth Brian J. Dose–response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. British Journal of Clinical Pharmacology 2001. DOI: 10.1046/j.0306-5251.2001.bjcp.1399.x. PMID: 11453895. PMCID: PMC2014508.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]